Interactions between two specific subsets of immune cells may contribute to disease activity in people with immunoglobulin G4-related disease (IgG4-RD), according to a new study. Researchers speculated that this newly identified immune-related axis could be a potential target for new IgG4-RD treatments. The study, “Extrafollicular [Tph2–CD11c-positive,…
Discussion
Those of us with rare conditions like IgG4-related disease often talk about the struggle to access affordable and equitable healthcare, but what happens after we temporarily overcome those hurdles? I say “temporarily” because, as many of us know, the obstacles never truly end. We’re constantly forced to jump through…
Azathioprine, an immunosuppressive medication, may help keep immunoglobulin G4-related disease (IgG4-RD) under control over the long term, while reducing glucocorticoid, or steroid, use, according to a small real-world study in Austria. In most of the 10 patients evaluated, azathioprine — primarily used to treat immune diseases — was…
Get regular updates to your inbox.
